Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 31;18(1):2016007.
doi: 10.1080/21645515.2021.2016007. Epub 2022 Mar 16.

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States

Elissa Meites  1 , Timothy J Wilkin  2 , Lauri E Markowitz  1
Affiliations
Review

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States

Elissa Meites et al. Hum Vaccin Immunother. .

Abstract

Gay, bisexual, and other men who have sex with men (MSM) and transgender women, particularly those who are living with HIV, are disproportionately affected by human papillomavirus (HPV). For this narrative review of HPV health outcomes and vaccination for gay, bisexual, and other MSM and transgender women in the United States, we highlighted 71 publications regarding 1) burden of HPV infections and related diseases; 2) HPV vaccine efficacy; 3) HPV vaccination recommendations; 4) HPV vaccination coverage; 5) real-world vaccine effectiveness and health impacts; and 6) HPV vaccination acceptability. Vaccination is effective at reducing HPV infections among MSM; in the United States, routine HPV vaccination is recommended for all adolescents at age 11-12 years and for all persons through age 26 years. Efforts are ongoing to increase vaccination coverage and monitor health impacts of vaccination. Increasing vaccination coverage before sexual exposure to HPV is expected to reduce the burden of HPV-related disease.

Keywords: Papillomavirus infections; papillomavirus vaccines; sexual and gender minorities; vaccination coverage.

PubMed Disclaimer

Conflict of interest statement

TJW has received grant funding paid to Weill-Cornell Medicine from Merck and GlaxoSmithKine/Viiv Healthcare, and has received honoraria from Merck. No potential conflictof interest was reported by the other authors.

References

    1. Zeeman L, Sherriff N, Browne K, McGlynn N, Mirandola M, Gios L, Davis R, Sanchez-Lambert J, Aujean S, Pinto N, et al. A review of lesbian, gay, bisexual, trans and intersex (LGBTI) health and healthcare inequalities. Eur J Public Health. 2019;29(5):974–8. doi:10.1093/eurpub/cky226. - DOI - PMC - PubMed
    1. Lewis RM, Laprise JF, Gargano JW, Unger ER, Querec TD, Chesson HW, Brisson M, Markowitz LE.. Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States. Sex Transm Dis. 2021;48(4):273–77. doi:10.1097/OLQ.0000000000001356. - DOI - PMC - PubMed
    1. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr., Unger ER; Centers for Disease Control and Prevention . Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP):. MMWR Recomm Rep. 2014;63:1–30. - PubMed
    1. Centers for Disease Control and Prevention . Cancers Associated with Human Papillomavirus, United States—2013–2017. United States Cancer Statistics Data Brief, no.18.Atlanta, GA: Centers for Disease Control and Prevention.2020.
    1. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698–702. doi:10.15585/mmwr.mm6832a3. - DOI - PMC - PubMed

Publication types

Substances